BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31154042)

  • 1. Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease.
    Caverly LJ; Huang YJ; Sze MA
    Chest; 2019 Aug; 156(2):376-382. PubMed ID: 31154042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases.
    Magryś A
    Pol J Microbiol; 2021 Mar; 70(1):25-32. PubMed ID: 33815524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology.
    Larsen JM; Musavian HS; Butt TM; Ingvorsen C; Thysen AH; Brix S
    Immunology; 2015 Feb; 144(2):333-42. PubMed ID: 25179236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures.
    Ghosh A; Saha S
    J Med Microbiol; 2022 Dec; 72(12):. PubMed ID: 36748565
    [No Abstract]   [Full Text] [Related]  

  • 5. The Lung Microbiome and Airway Disease.
    Lynch SV
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 2(Suppl 5):S462-S465. PubMed ID: 28005424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.
    Caverly LJ; LiPuma JJ
    Expert Rev Respir Med; 2018 Oct; 12(10):857-865. PubMed ID: 30118374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.
    Mendez R; Banerjee S; Bhattacharya SK; Banerjee S
    IUBMB Life; 2019 Feb; 71(2):152-165. PubMed ID: 30466159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
    Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
    J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The lung microbiome in 2015: a window on chronic lung diseases].
    Andréjak C; Delhaes L
    Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the bacterial microbiome in lung disease.
    Dickson RP; Erb-Downward JR; Huffnagle GB
    Expert Rev Respir Med; 2013 Jun; 7(3):245-57. PubMed ID: 23734647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Human Respiratory Microbiome: Current Understandings and Future Directions.
    Zhao L; Luo JL; Ali MK; Spiekerkoetter E; Nicolls MR
    Am J Respir Cell Mol Biol; 2023 Mar; 68(3):245-255. PubMed ID: 36476129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis.
    Boutin S; Depner M; Stahl M; Graeber SY; Dittrich SA; Legatzki A; von Mutius E; Mall M; Dalpke AH
    Mediators Inflamm; 2017; 2017():5047403. PubMed ID: 29445257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-microbe interactions in distal airways: relevance to chronic airway diseases.
    Martin C; Burgel PR; Lepage P; Andréjak C; de Blic J; Bourdin A; Brouard J; Chanez P; Dalphin JC; Deslée G; Deschildre A; Gosset P; Touqui L; Dusser D
    Eur Respir Rev; 2015 Mar; 24(135):78-91. PubMed ID: 25726559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral-lung microbiome interactions in lung diseases.
    Mammen MJ; Scannapieco FA; Sethi S
    Periodontol 2000; 2020 Jun; 83(1):234-241. PubMed ID: 32385873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications.
    Huang YJ; Lynch SV
    Expert Rev Respir Med; 2011 Dec; 5(6):809-21. PubMed ID: 22082166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lung microbiome in health and disease.
    Moffatt MF; Cookson WO
    Clin Med (Lond); 2017 Dec; 17(6):525-529. PubMed ID: 29196353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease.
    Park H; Shin JW; Park SG; Kim W
    PLoS One; 2014; 9(10):e109710. PubMed ID: 25329665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic diversity and antimicrobial resistance of
    Webb KA; Olagoke O; Baird T; Neill J; Pham A; Wells TJ; Ramsay KA; Bell SC; Sarovich DS; Price EP
    Microb Genom; 2022 Feb; 8(2):. PubMed ID: 35113778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Respiratory Flora in the Pathogenesis of Chronic Respiratory Diseases.
    Guo MY; Chen HK; Ying HZ; Qiu FS; Wu JQ
    Biomed Res Int; 2021; 2021():6431862. PubMed ID: 34435047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.